Distinct EGFR Mutation Pattern in Patients With Non-Small Cell Lung Cancer in Xuanwei Region of China: A Systematic Review and Meta-Analysis
- PMID: 33224870
- PMCID: PMC7667261
- DOI: 10.3389/fonc.2020.519073
Distinct EGFR Mutation Pattern in Patients With Non-Small Cell Lung Cancer in Xuanwei Region of China: A Systematic Review and Meta-Analysis
Abstract
Background: In the Xuanwei region of China, lung cancer incidence and mortality are among the highest in China, attributed to severe air pollution generated by combustion of smoky coal. No study has yet comprehensively evaluated the prevalence of epidermal growth factor receptor (EGFR) mutation characteristics in patients with non-small cell lung cancer (NSCLC) in Xuanwei. This meta-analysis was designed to analyze the EGFR mutation pattern in NSCLC patients in Xuanwei region of Yunnan Province in China.
Methods: Electronic databases were comprehensively searched and relevant literatures were retrieved. The odds ratio (OR) for EGFR mutations between Xuanwei region and non-Xuanwei region was calculated, and the absolute incidence of EGFR mutations in Xuanwei was pooled by mutation subtype.
Results: Seven studies involving 1,355 patients with NSCLC from Yunnan Province (442 in Xuanwei and 913 in other regions) were included. The EGFR mutation rate ranged between 30.19% and 55.56%. Higher uncommon EGFR mutations (OR: 5.69, 95%CI: 2.23-14.49, P<0.001) and lower common EGFR mutations (OR: 0.18, 95%CI: 0.07-0.45, P<0.001) were found in Xuanwei region, compared with non-Xuanwei region. Specifically, the uncommon EGFR mutation rate was 59.50% and common EGFR mutation rate was 40.50% in Xuanwei. The mutation incidence of exon 18 G719X (OR: 3.21, 95%CI: 1.48-6.97, P=0.003), exon 20 S768I (OR: 6.44; 95%CI: 2.66-15.60; P<0.001), and exon 18 G719X + 20 S768I (OR: 6.55; 95%CI: 1.92-22.33; P=0.003) in Xuanwei were significantly higher, while the frequency of 19 deletion (OR: 0.28, 95%CI: 0.11-0.77, P<0.001) and 21 L858R mutation (OR: 0.51, 95%CI: 0.31-0.84, P=0.007) were lower.
Conclusions: The results highlight the distinct EGFR mutation spectrum of NSCLC patients in Xuanwei region compared with other regions, with higher uncommon mutations but lower common mutations. The distinct Xuanwei featured genetic variations provide a unique model to further study carcinogenesis of lung cancer.
Keywords: China; EGFR mutation; Xuanwei; lung cancer; subtype.
Copyright © 2020 Lv, Liu, Liu, Zhang, Jiang, Li, Lu, Lei, Liang and Lin.
Figures


Similar articles
-
Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study.Front Oncol. 2023 Oct 10;13:1156647. doi: 10.3389/fonc.2023.1156647. eCollection 2023. Front Oncol. 2023. PMID: 37881485 Free PMC article.
-
[Analysis of EGFR mutation and clinical features of lung cancer in Yunnan].Zhonghua Zhong Liu Za Zhi. 2020 Sep 23;42(9):729-734. doi: 10.3760/cma.j.cn112152-20200313-00201. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32988154 Chinese.
-
[Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].Zhonghua Bing Li Xue Za Zhi. 2016 Apr 8;45(4):226-30. doi: 10.3760/cma.j.issn.0529-5807.2016.04.003. Zhonghua Bing Li Xue Za Zhi. 2016. PMID: 27033384 Chinese.
-
The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China.Front Med. 2012 Dec;6(4):388-94. doi: 10.1007/s11684-012-0233-3. Epub 2012 Dec 7. Front Med. 2012. PMID: 23224416 Review.
-
Successful Treatment of a Patient with Lung Adenocarcinoma Harboring Compound EGFR Gene Mutations, G719X and S768I, with Afatinib.Tokai J Exp Clin Med. 2020 Sep 20;45(3):113-116. Tokai J Exp Clin Med. 2020. PMID: 32901897 Review.
Cited by
-
Comprehensive analysis of the transcription factor CREB3L4/RASEF signaling axis in lung adenocarcinoma: implications for pathogenesis and therapeutic strategies.Am J Transl Res. 2024 Nov 15;16(11):6399-6422. doi: 10.62347/JAHC2715. eCollection 2024. Am J Transl Res. 2024. PMID: 39678581 Free PMC article.
-
Different gene alterations in patients with non-small-cell lung cancer between the eastern and southern China.Heliyon. 2023 Sep 14;9(10):e20171. doi: 10.1016/j.heliyon.2023.e20171. eCollection 2023 Oct. Heliyon. 2023. PMID: 37767514 Free PMC article.
-
Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China.Genes Environ. 2022 May 23;44(1):17. doi: 10.1186/s41021-022-00248-z. Genes Environ. 2022. PMID: 35606799 Free PMC article.
-
Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data.Front Pharmacol. 2024 Jul 25;15:1428158. doi: 10.3389/fphar.2024.1428158. eCollection 2024. Front Pharmacol. 2024. PMID: 39130636 Free PMC article.
-
Unique Profile of Driver Gene Mutations in Patients With Non-Small-Cell Lung Cancer in Qujing City, Yunnan Province, Southwest China.Front Oncol. 2021 Apr 13;11:644895. doi: 10.3389/fonc.2021.644895. eCollection 2021. Front Oncol. 2021. PMID: 33928034 Free PMC article.
References
-
- Baek JH, Sun JM, Min YJ, Cho EK, Cho BC, Kim JH, et al. Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 l858r: A retrospective analysis in korea. Lung Cancer (Amsterdam Netherlands) (2015) 87:148–54. 10.1016/j.lungcan.2014.11.013 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous